Overview
- Description of a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment
- 11 chapters written by established leaders in the world
- Valuable tools for academics working in the field of cancer research and apoptosis as well as pharmaceutical and pharmacological industries
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
Keywords
About this book
Reviews
From the reviews:
“This book is appropriate for scientific professionals in the field of basic cancer research, drug development, and cancer medicine, as well as professionals in the pharmaceutical and pharmacological industries. … This book provides well-summarized information on interesting anticancer agents which have been substantially studied recently on their ability to induce apoptosis in cancer cells. … The book is a good source of information for the scientific community and medicinal industries who are interested in development of anticancer drugs.” (Qi Chen, Doody’s Review Service, January, 2013)
Editors and Affiliations
Bibliographic Information
Book Title: Novel Apoptotic Regulators in Carcinogenesis
Editors: George G. Chen, Paul B.S. Lai
DOI: https://doi.org/10.1007/978-94-007-4917-7
Publisher: Springer Dordrecht
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media Dordrecht 2012
Hardcover ISBN: 978-94-007-4916-0Published: 21 August 2012
Softcover ISBN: 978-94-007-9493-1Published: 21 September 2014
eBook ISBN: 978-94-007-4917-7Published: 28 August 2012
Edition Number: 1
Number of Pages: XII, 300
Topics: Biomedicine general, Medicine/Public Health, general, Entomology